84 related articles for article (PubMed ID: 21519537)
1. Mirtazapine augmentation for selective serotonin reuptake inhibitor-induced sexual dysfunction: a retropective investigation.
Atmaca M; Korkmaz S; Topuz M; Mermi O
Psychiatry Investig; 2011 Mar; 8(1):55-7. PubMed ID: 21519537
[TBL] [Abstract][Full Text] [Related]
2. Mirtazapine augmentation in depressed patients with sexual dysfunction due to selective serotonin reuptake inhibitors.
Ozmenler NK; Karlidere T; Bozkurt A; Yetkin S; Doruk A; Sutcigil L; Cansever A; Uzun O; Ozgen F; Ozsahin A
Hum Psychopharmacol; 2008 Jun; 23(4):321-6. PubMed ID: 18278806
[TBL] [Abstract][Full Text] [Related]
3. The use of mirtazapine in a group of 11 patients following poor compliance to selective serotonin reuptake inhibitor treatment due to sexual dysfunction.
Koutouvidis N; Pratikakis M; Fotiadou A
Int Clin Psychopharmacol; 1999 Jul; 14(4):253-5. PubMed ID: 10468319
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of add on low-dose mirtazapine in depression.
Matreja PS; Badyal DK; Deswal RS; Sharma A
Indian J Pharmacol; 2012 Mar; 44(2):173-7. PubMed ID: 22529470
[TBL] [Abstract][Full Text] [Related]
5. Pharmacologic approaches to treatment resistant depression: Evidences and personal experience.
Tundo A; de Filippis R; Proietti L
World J Psychiatry; 2015 Sep; 5(3):330-41. PubMed ID: 26425446
[TBL] [Abstract][Full Text] [Related]
6. Mirtazapine : A Review of its Pharmacology and Therapeutic Potential in the Management of Major Depression.
Davis R; Wilde MI
CNS Drugs; 1996 May; 5(5):389-402. PubMed ID: 26071050
[TBL] [Abstract][Full Text] [Related]
7. Sexual dysfunction in selective serotonin reuptake inhibitors (SSRIs) and potential solutions: A narrative literature review.
Jing E; Straw-Wilson K
Ment Health Clin; 2016 Jul; 6(4):191-196. PubMed ID: 29955469
[TBL] [Abstract][Full Text] [Related]
8. Effect of mirtazapine versus selective serotonin reuptake inhibitors on benzodiazepine use in patients with major depressive disorder: a pragmatic, multicenter, open-label, randomized, active-controlled, 24-week trial.
Hashimoto T; Shiina A; Hasegawa T; Kimura H; Oda Y; Niitsu T; Ishikawa M; Tachibana M; Muneoka K; Matsuki S; Nakazato M; Iyo M
Ann Gen Psychiatry; 2016; 15():27. PubMed ID: 27777607
[TBL] [Abstract][Full Text] [Related]
9. Mirtazapine: a review of its use in major depression.
Holm KJ; Markham A
Drugs; 1999 Apr; 57(4):607-31. PubMed ID: 10235695
[TBL] [Abstract][Full Text] [Related]
10. Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorder.
Foster RH; Goa KL
CNS Drugs; 1997 Aug; 8(2):163-88. PubMed ID: 23338224
[TBL] [Abstract][Full Text] [Related]
11. Treatment with selective serotonin reuptake inhibitors and mirtapazine results in differential brain activation by visual erotic stimuli in patients with major depressive disorder.
Kim W; Jin BR; Yang WS; Lee KU; Juh RH; Ahn KJ; Chung YA; Chae JH
Psychiatry Investig; 2009 Jun; 6(2):85-95. PubMed ID: 20046380
[TBL] [Abstract][Full Text] [Related]
12. Assessment of sexual functioning in depressed patients treated with mirtazapine: a naturalistic 6-month study.
Saiz-Ruiz J; Montes JM; Ibáñez A; Díaz M; Vicente F; Pelegrín C; Viñas R; Arias F; Carrasco JL; Ferrando L
Hum Psychopharmacol; 2005 Aug; 20(6):435-40. PubMed ID: 16106478
[TBL] [Abstract][Full Text] [Related]
13. Add-on mirtazapine improves orgasmic functioning in patients with schizophrenia treated with first-generation antipsychotics.
Terevnikov V; Stenberg JH; Tiihonen J; Burkin M; Joffe G
Nord J Psychiatry; 2017 Jan; 71(1):77-80. PubMed ID: 27701952
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of mirtazapine and SSRIs in late-life depression: post hoc analysis of the GUNDAM study.
Kato M; Baba H; Takekita Y; Naito M; Koshikawa Y; Bandou H; Kinoshita T
Eur J Clin Pharmacol; 2023 Nov; 79(11):1515-1524. PubMed ID: 37700038
[TBL] [Abstract][Full Text] [Related]
15. A pilot study of mirtazapine in post-traumatic stress disorder.
Connor KM; Davidson JR; Weisler RH; Ahearn E
Int Clin Psychopharmacol; 1999 Jan; 14(1):29-31. PubMed ID: 10221639
[TBL] [Abstract][Full Text] [Related]
16. Drug use evaluation: A two-year retrospective review of the effectiveness and tolerability of agomelatine versus mirtazapine in patients with depressive disorder.
Leung SM
Brain Behav; 2021 Aug; 11(8):e2311. PubMed ID: 34333871
[TBL] [Abstract][Full Text] [Related]
17. A randomized, double-blind, 24-week study comparing the efficacy and tolerability of mirtazapine and paroxetine in depressed patients in primary care.
Wade A; Crawford GM; Angus M; Wilson R; Hamilton L
Int Clin Psychopharmacol; 2003 May; 18(3):133-41. PubMed ID: 12702891
[TBL] [Abstract][Full Text] [Related]
18. Rosa damascena oil improves SSRI-induced sexual dysfunction in male patients suffering from major depressive disorders: results from a double-blind, randomized, and placebo-controlled clinical trial.
Farnia V; Shirzadifar M; Shakeri J; Rezaei M; Bajoghli H; Holsboer-Trachsler E; Brand S
Neuropsychiatr Dis Treat; 2015; 11():625-35. PubMed ID: 25834441
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and tolerability of mirtazapine versus citalopram: a double-blind, randomized study in patients with major depressive disorder. Nordic Antidepressant Study Group.
Leinonen E; Skarstein J; Behnke K; Agren H; Helsdingen JT
Int Clin Psychopharmacol; 1999 Nov; 14(6):329-37. PubMed ID: 10565799
[TBL] [Abstract][Full Text] [Related]
20. Adjunctive vortioxetine for SSRI-resistant major depressive disorder: a "real-world" chart review study.
De Berardis D; Fornaro M; Anastasia A; Vellante F; Olivieri L; Rapini G; Serroni N; Orsolini L; Valchera A; Carano A; Tomasetti C; Ventriglio A; Bustini M; Pompili M; Serafini G; Perna G; Iasevoli F; Martinotti G; Di Giannantonio M
Braz J Psychiatry; 2020; 42(3):317-321. PubMed ID: 32159712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
